Sham portfolio

Sham has 2 portfolio companies on record at Recent Funding.

Type: Investor.

Portfolio on Recent Funding: 2.

Deals, last 12 months: 0.

Capital in their rounds: $80M.

Latest deal: Amolyt Pharma · Sep 1, 2021.

About this page

Its most recent investment on record is Amolyt Pharma's $80M Series B+ round in September 2021, alongside EQT Life Sciences, Mass General Brigham Ventures, Pontifax and 6 others. By category, its portfolio leans toward Health and bio (2) and Consumer and social (1).

What Sham invests in

Health and bio · 2 · 100%
Consumer and social · 1 · 50%

How Sham invests

Stage	Deals	Capital in rounds
Series B+	1 100%	$80M

Sham portfolio companies

AAmolyt Pharma$80MSeries B+ · Sep 2021
GGermitecbacker

Company	Round with Sham	Total raised	Latest raise
AAmolyt Pharma Health and bio	Sep 1, 2021 Series B+ · $80M	$294M	Jan 6, 2023 Series B+
GGermitec Health and bio	backer	$28.8M	Feb 12, 2025 round

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Sham. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Sham, which is a subset of its real portfolio. API: /api/v1/investors/sham (get a free API key). More: the most active VC firms and new venture capital funds.